(Q33880241)

29 July 2017

Incomplete reversibility of estimated glomerular filtration rate decline following tenofovir disoproxil fumarate exposure (English)

1 reference

29 July 2017

1 reference

Sophie Jose

1

0 references

Caroline Sabin

object named as

Caroline A Sabin

15

0 references

David Chadwick

12

object named as

David Chadwick

1 reference

29 July 2017

2

Lisa Hamzah

1 reference

29 July 2017

Lucy J Campbell

3

1 reference

29 July 2017

Teresa Hill

4

1 reference

29 July 2017

Martin Fisher

5

1 reference

29 July 2017

Clifford Leen

6

1 reference

29 July 2017

Richard Gilson

7

1 reference

29 July 2017

John Walsh

8

1 reference

29 July 2017

Mark Nelson

9

1 reference

29 July 2017

Phillip Hay

10

1 reference

29 July 2017

Margaret Johnson

11

1 reference

29 July 2017

Dorothea Nitsch

13

1 reference

29 July 2017

Rachael Jones

14

1 reference

29 July 2017

Frank A Post

16

1 reference

29 July 2017

UK Collaborative HIV Cohort Study Steering Committee

17

1 reference

29 July 2017

language of work or name

English

0 references

publication date

28 February 2014

1 reference

Journal of Infectious Diseases

29 July 2017

1 reference

29 July 2017

210

1 reference

29 July 2017

3

1 reference

29 July 2017

363-373

1 reference

Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International

29 July 2017

start time

16 January 2017

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

The Uncertainty of the eGFR.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091582

Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091582

Association of tenofovir exposure with kidney disease risk in HIV infection

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091582

Relationship between renal dysfunction, nephrotoxicity and death among HIV adults on tenofovir

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091582

Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091582

Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091582

The effects of HIV type-1 viral suppression and non-viral factors on quantitative proteinuria in the highly active antiretroviral therapy era

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091582

Tenofovir-associated renal and bone toxicity

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091582

A new equation to estimate glomerular filtration rate

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091582

Predictors of kidney tubular dysfunction in HIV-infected patients treated with tenofovir: a pharmacogenetic study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091582

Spectrum of chronic kidney disease in HIV-infected patients.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091582

Acute renal failure and Fanconi syndrome in an AIDS patient on tenofovir treatment--case report and review of literature

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091582

Biological effects of short-term or prolonged administration of 9-[2-(phosphonomethoxy)propyl]adenine (tenofovir) to newborn and infant rhesus macaques

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091582

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091582

Assessment of mitochondrial toxicity in human cells treated with tenofovir: comparison with other nucleoside reverse transcriptase inhibitors

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091582

Nucleoside phosphonate interactions with multiple organic anion transporters in renal proximal tubule

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091582

Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel.

28 July 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU107

Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU107

Tenofovir DF in antiretroviral-experienced patients: results from a 48-week, randomized, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU107

Impact of tenofovir on renal function in HIV-infected, antiretroviral-naive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU107

Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU107

Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU107

Fanconi syndrome and renal failure induced by tenofovir: a first case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU107

Progressive renal tubular dysfunction associated with long-term use of tenofovir DF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU107

Incomplete reversibility of tenofovir-related renal toxicity in HIV-infected men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU107

High rate of reversibility of renal damage in a cohort of HIV-infected patients receiving tenofovir-containing antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU107

The creation of a large UK-based multicentre cohort of HIV-infected individuals: The UK Collaborative HIV Cohort (UK CHIC) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU107

Comparison of CKD-EPI and MDRD to estimate baseline renal function in HIV-positive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU107

Renal transport of adefovir, cidofovir, and tenofovir by SLC22A family members (hOAT1, hOAT3, and hOCT2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU107

Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU107

Evaluation of mitochondrial DNA content and enzyme levels in tenofovir DF-treated rats, rhesus monkeys and woodchucks

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU107

Association between tenofovir exposure and reduced kidney function in a cohort of HIV-positive patients: results from 10 years of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU107

Persistent decline in estimated but not measured glomerular filtration rate on tenofovir may reflect tubular rather than glomerular toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU107

Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU107

Predicting tenofovir concentration on the basis of renal factors determined by routine tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU107

Circadian variability of cystatin C, creatinine, and glomerular filtration rate (GFR) in healthy men during normal sleep and after an acute shift of sleep

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU107

Biological variation of cystatin C and creatinine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU107

Tenofovir use is associated with a reduction in calculated glomerular filtration rates in the Swiss HIV Cohort Study.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091582

Tenofovir Disoproxil Fumarate, Emtricitabine, and Efavirenz Versus Fixed-Dose Zidovudine/Lamivudine and Efavirenz in Antiretroviral-Naive Patients

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091582

Intra-individual variation in creatinine and cystatin C

29 October 2018

1 reference

12 December 2020

Assessing recovery of renal function after tenofovir disoproxil fumarate discontinuation

1 reference

12 December 2020

1 reference

12 December 2020

Increased time exposure to tenofovir is associated with a greater decrease in estimated glomerular filtration rate in HIV patients with kidney function of less than 60 ml/min/1.73 m2

1 reference

12 December 2020

Pharmacokinetics and safety of tenofovir disoproxil fumarate on coadministration with lopinavir/ritonavir

1 reference

12 December 2020

Identifiers

DOI

10.1093/INFDIS/JIU107

1 reference

29 July 2017

1 reference

29 July 2017

1 reference